Induced biosyntheses of a novel butyrophenone and two aromatic polyketides in the plant pathogen Stagonospora nodorum by Xiao-Long Yang et al.
Regular Article                                                                                                                                  Nat. Prod. Bioprospect. 2013, 3, 141–144 
DOI 10.1007/s13659-013-0055-2 
 
         
Induced biosyntheses of a novel butyrophenone and two aromatic 
polyketides in the plant pathogen Stagonospora nodorum 
Xiao-Long YANG,a,b Takayoshi AWAKAWA,a Toshiyuki WAKIMOTO,a and Ikuro ABEa,* 
aGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan 
bCollege of Pharmaceutical Science, Hebei University, Baoding 071002, China 
 
Received 17 July 2013; Accepted 4 August 2013 
© The Author(s) 2013. This article is published with open access at Springerlink.com 
 
Abstract: Fungal aromatic compounds comprise an important and structurally diverse group of secondary metabolites. Several 
genome sequencing projects revealed many putative biosynthetic gene clusters of fungal aromatic compounds, but many of these 
genes seem to be silent under typical laboratory culture conditions. To gain access to this untapped reservoir of natural products, we 
utilized chemical epigenetic modifiers to induce the expression of dormant biosynthetic genes. As a result, the concomitant  
supplementation of the histone deacetylase inhibitors suberoylanilide hydroxamic acid (500 M) and nicotinamide (50 M) to the 
culture medium of a fungal pathogen, Stagonospora nodorum, resulted in the isolation of three aromatic compounds (1–3),  
including a novel natural butyrophenone, (+)-4'-methoxy-(2S)-methylbutyrophenone (1), and two known polyketides, alternariol (2) 
and (–)-(3R)-mellein methyl ether (3). 
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Introduction 
Fungal aromatic compounds are structurally and functionally
diverse, as exemplified by the mycotoxin aflatoxin, the  
pigment emodin, and the antifungal drug griseofulvin.1–3 Some 
of them are produced by polyketide synthases (PKSs), and 
have been linked to their biosynthetic genes. However, there 
are a large number of PKS genes with products that have not 
been identified in several fungal genome sequences, indicating 
that numerous cryptic biosynthetic pathways of natural  
products remain to be discovered. Stagonospora nodorum is a 
destructive wheat pathogen.4 It belongs to Dothideomycetes, a 
class of filamentous fungi that includes many plant pathogens, 
and thus important as a model for pathology study. Previous 
studies aiming toward the comprehension of plant diseases 
demonstrated the critical roles of host-specific proteinaceous 
toxins and various primary metabolic pathways for effective 
fungal pathogenicity.5–9 Nevertheless, only a few papers  
regarding the capacity of this strain to produce secondary  
metabolites have been published, except for one mycotoxin, 
alternariol.8 Recently, the whole genome sequence of S.  
nodorum revealed that it contains 19 genes encoding PKSs, 8 
genes encoding non-ribosomal peptide synthetases (NRPSs), 
and one gene encoding a PKS-NRPS hybrid, to produce cryptic
natural products that outnumber the currently known  
metabolites from this fungus.10 However, many of these  
putative biosynthetic genes seem to be silent under a variety of 
laboratory culturing conditions. To trigger the expression of 
these gene clusters, an effective method is to use epigenetic 
modifying agents, including histone deacetylase (HDAC) and 
DNA methyltransferase inhibitors, for manipulating the fungal 
epigenome.11 In our study, screening of the secondary  
metabolites produced by S. nodorum, grown in the presence of 
these inhibitors, revealed that the concomitant supplementation 
of the HDAC inhibitors to the culture medium induced  
significant changes in the production of metabolites. This  
finding led to the isolation of a novel natural butyrophenone, 
(+)-4'-methoxy-(2S)-methylbutyrophenone (1), along with two 
known aromatic polyketides, alternariol (2) and (–)-(3R)-
mellein methyl ether (3). Details of the isolation and structural 
elucidation of 1–3 are reported herein. 
 
Results and Discussion 
S. nodorum FGSC 10173 was incubated in 100 mL of potato
dextrose broth (PDB), in the presence and absence of 500 M 
SBHA and 50 M nicotinamide. The ethyl acetate extract of 
the culture filtrate was analyzed by high performance liquid 
chromatography (HPLC). As a result, the production of two 
new products (1 and 3) was induced, and the intensity of one 
peak for compound 2 was enhanced (Figure 1). 
Compound 1 was obtained as a white solid. Its molecular 
formula was established as C12H16O2, by a pseudomolecular 
ion peak at m/z 193.1234 [M + H]+ (calcd for C12H17O2, 
193.1223) in the positive HRESIMS, with 5 degrees of  
unsaturation. The 1H NMR analysis revealed the presence of a 
1,4-disubstituted aromatic ring (δH 7.71 (2H, d, J = 8.5 Hz), 
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6.80 (2H, d, J = 8.5 Hz)), three methyl groups (δH 3.85 (3H, s), 
1.25 (3H, d, J = 6.5 Hz), 0.89 (3H, t, J = 7.5 Hz)), one methine 
group (δH 3.15 (1H, m)), and one methylene group (δH 1.60 
(1H, m), 1.85 (1H, m)). Analyses of its 13C NMR, HSQC and 
1H-1H COSY data further revealed the presence of a 1,4-
disubstituted aromatic ring (δC 128.0 (s, C-1'), 132.7 (d, C-2', 
and 6'), 114.9 (d, C-3', and 5'), 163.3 (s, C-4')), one methoxy 
carbon (δC 52.9 (q, C-7')), and a 2-methylbutan-1-one moiety 
(δC 191.5 (s, C-1), 36.5 (d, C-2), 27.8 (t, C-3) 11.0 (q, C-4), 
17.4 (q, C-5)). Further detailed interpretation of the HMBC  
correlations from H-2' and H-6' to C-1, and from H-7' to C-4', 
allowed us to assign the methoxy group and the 2-
methylbutan-1-one moiety to C-4' and C-1', respectively.  
Finally, compound 1 was identified as (+)-4'-methoxy-(2S)-
methylbutyrophenone (Figure 2), which was previously  
reported as a synthetic compound.12 The absolute configuration
of C-2 was determined to be S, by comparing its optical  
rotation to the reported value.12 
Compound 2 was obtained as a white solid. Its molecular 
formula was established as C14H10O5, by a pseudomolecular 
ion peak at m/z 259.0612 [M + H]+ (calcd for C14H11O5, 
259.0601) in the positive HRESIMS. Analyses of its 13C NMR 
and HSQC data revealed 14 carbon resonances,  
including one ester carbonyl carbon, four aromatic methine 
carbons, eight aromatic quaternary carbons, and one methyl 
carbon. The 1H NMR spectrum also displayed four sp2  
methines (δH 6.34 (1H, d, J = 1.7 Hz, H-4), 7.21 (1H, d, J = 
1.7 Hz, H-6), 6.61 (1H, d, J = 2.3 Hz, H-3'), 6.69 (1H, d, J = 
2.3 Hz, H-5')), featuring two 1,2,3,5-tetrasubstituted aromatic 
rings deduced from their coupling constants, and one methyl 
(δH 2.68 (3H, s, H-7')). Thus, its NMR data were identical to 
those of alternariol, a known mycotoxin metabolite from the 
mold Alternaria tenuis.13 
Compound 3 was obtained as a white solid. Its molecular 
formula was established as C11H12O3, by a pseudo-molecular 
ion peak at m/z 193.0837 [M + H]+ (calcd for C11H13O3, 
193.0859) in the positive HRESIMS. Analysis of the 1H NMR 
spectrum revealed the presence of 1,2,3-trisubstituted aromatic 
ring signals (δH 6.85 (1H, d, J = 7.5 Hz, H-5), 7.47 (1H, dd, J 
= 8.5, 7.5 Hz, H-6), 7.00 (1H, d, J = 8.5  Hz, H-7)), one oxy-
genated methine (δH 4.45 (1H, m, H-3)), one  
methylene (δH 2.87 (2H, m, H-4)), and two methyls (δH 1.31 
(3H, d, J = 7.0 Hz, H-9), 3.77 (3H, s, H-10)). The 13C NMR 
spectrum revealed 11 carbon signals, due to one ester carbonyl, 
three aromatic methine carbons, three aromatic quaternary 
carbons, one oxygenated methine carbon, one methylene  
carbon, and two methyl carbons. A comparison of the NMR 
data and the optical rotation value revealed that 3 is identical 
to (–)-(3R)-mellein methyl ether, previously isolated from the 
mangrove-derived fungus Xylaria cubensis (Figure 2).14 
Compounds 1–3 were tested for their antifungal activities 
against three fungal strains, including Fusarium solani,  
Aspergillus terreus and Candida albicans.15 The results 
showed that these three compounds displayed moderate  
activities against the three tested fungal strains (Table 1). 
Although S. nodorum contains 19 genes encoding PKSs, 
few polyketides were discovered from this fungus.  
Interestingly, these PKS gene clusters are dormant under  
normal culture conditions, but the concomitant supplementation
of the HDAC inhibitors SBHA (500 M) and nicotinamide (50 
M) to the culture medium of S. nodorum facilitated the  
production of three aromatic compounds (1–3). Upon further 
 
Figure 1.  HPLC analyses of culture broths of S. nodorum: (A) Incubated in PDB, (B) Incubated in PDB containing SBHA 
(500 M) + nicotinamide (50 M). Elutions were monitored by UV absorption at 254 nm. 
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isolation, we identified the novel natural butyrophenone (1), 
together with two known aromatic polyketides (2 and 3). Our 
findings confirmed that chemical epigenetic manipulation is an 
effective strategy to access the biosynthetic potential of this 
fungus. 
The novel (+)-4'-methoxy-(2S)-methylbutyrophenone (1) 
could be derived from the polyketide biosynthetic pathway. A 
related compound, 1-(2,4,6-trihydroxyphenyl)butan-1-one, 
was isolated from the endophytic fungus Paeonia delavayi,16 
which led us to assume that the phloroglucinol precursor is 
possibly converted into the para-substituted phenol scaffold of 
1 by reductases. Furthermore, the (2S)-methylbutyryl moiety 
of 1 could be generated by a diketide-producing PKS, as in the 
case of the diketide side chain formation by LovF in lovastatin 
biosynthesis,17 and then transferred to another PKS that  
catalyzes three chain extensions and a Dieckmann  
condensation, to produce the phloroglucinol scaffold. In fact, 
we found SNOG_09623, encoding a PKS with the same  
domain organization as those of LovF, and SNOG_09622, 
encoding a type III PKS, in the S. nodorum genome. The two 
genes are clustered in the chromosome, but without any  
methyltransferase gene nearby. The polyketide chain transfer 
between two PKSs was reported for the bacterial PKS system 
of the alkylresorcinol and alkylpyrone biosynthesis in  
Azotobacter vinelandii18, and for the formation of 
phlorocaprophenone in Dictyostellium discoidium (type III 
PKS Steely 2).19 
On the other hand, although (–)-(3R)-mellein methyl ether 
(3) is widely distributed in fungi, its biosynthetic enzymes 
have not been reported. Recently, SACE5532 from the  
actinobacterium, Saccharopolyspora erythraea, which consists 
of ketosynthase (KS), acyltransferase (AT), thioester  
hydrolase (TH), and ketoreductase (KR) domains, was  
identified as a PKS that produces (R)-(–)-mellein.20 Therefore, 
a PKS with identical domains to those of SACE5532 in S. 
nodorum should be a candidate for a mellein PKS. Two PKS 
genes exist in S. nodorum, SNOG_00477 and SNOG_14927, 
and they encode PKSs with identical domain structures to 
those of SACE5532. Thus, one of them is likely to be the PKS 
that generates mellein. This information illustrates the  
application of chemical epigenetic manipulation to a genome-
sequenced strain, to provide helpful information toward  
identifying biosynthetic genes. 
 
Experimental Section 
HPLC Analysis of the Compounds Accumulated in the 
Broth of S. nodorum. S. nodorum FGSC 10173 was obtained 
from the Fungal Genetic Stock Center. The fungal strain was 
cultured on potato dextrose agar (PDA) at 28 °C for 7 days, 
and then inoculated into 100 mL of PDB containing 500 M 
SBHA and/or 50 M nicotinamide in 500 mL Erlenmeyer 
flasks, under shaking conditions at 28 ºC for 7 days. The  
culture broths were extracted three times with ethyl acetate. 
After evaporation in vacuo, the crude extracts were subjected 
to an HPLC analysis. The HPLC analysis was performed at a 
flow rate of 0.8 mL/min on an ODS column (Cosmosil 5C18 
PAQ Waters, 4.6  250 mm), with a mixture of H2O and 
CH3CN (0–30 min, 10–100% CH3CN; 30–50 min, 100% 
CH3CN; 50–55 min, 100–10% CH3CN). 
 
Isolation of Compounds (1–3). To isolate the induced 
compounds, S. nodorum was inoculated in 20  100 mL of 
PDB, containing 500 M SBHA and 50 M nicotinamide, in 
500 mL Erlenmeyer flasks under shaking conditions at 28 ºC 
for 7 days. The culture broths were extracted three times with 
ethyl acetate. After evaporation in vacuo, the crude extract was 
directly separated by preparative HPLC (Shimadzu, LC-20AD 
and SPD-20A Prominence Diode Array Detector), using a 
Cosmosil 5C18-PAQ Waters column (10 × 250 mm, Nacalai 
Tesque, Kyoto) eluted with a mixture of H2O (solvent A) and 
CH3CN (solvent B), both containing 0.1% acetic acid, at a 
flow rate of 2.5 mL/min. The separation performance was 
equivalent to that of the analytical method, which led to the 
isolation of 1 (1.28 mg, tR = 21.1 min, 35% CH3CN over 15 
min), 2 (2.28 mg, tR = 17.8 min, 35% CH3CN over 15 min), 
and 3 (6.96 mg, tR = 16.7 min, 35% CH3CN over 15 min). 
 
Antifungal Activity Assays. Antifungal bioassays were 
conducted according to the previously reported procedure.15 
The fungal strains, Fusarium solani, Aspergillus terreus and 
Candida albicans, were grown on PDA. Targeted microbes 
(3–4 colonies) were prepared from broth cultures (28 ºC for  
 
Figure 2.  The structures of compounds 1–3 




1 2 3 ketoconazole 
Fusarium solani 50 10 100 > 100 
Aspergillus terreus 50 50 50 25 
Candida albicans > 100 50 > 100 3.1 
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72 h), and the final fungal spore suspensions (in PDB) were 
104 mycelial fragments/mL. Test samples (10 mg/mL as a 
stock solution in DMSO and serial dilutions) were transferred 
to a 96-well clear plate in triplicate, and the suspension of the 
test organisms was added to each well, to achieve a final vol-
ume of 100 μL (ketoconazole was used as the positive control). 
After incubation, the minimum inhibitory concentration (MIC) 
was defined as the lowest test concentration that completely 
inhibited the growth of the test organisms. 
 
(+)-4'-Methoxy-(2S)-methylbutyrophenone (1): white 
solid; [α]24D   + 7.5 (c 0.07, MeOH); UV (MeOH) λmax (log ε) 
265, 284, 315 nm; 1H NMR (CD3OD, 500 MHz): δ 0.89 (3H, t, 
J = 7.5 Hz, H-4), 1.25 (3H, d, J = 6.5 Hz, H-5), 1.60 (1H, m, 
H-3a), 1.85 (1H, m, H-3b), 3.15 (1H, m, H-2), 3.85 (3H, s, H-
7'), 6.80 (2H, d, J = 8.5 Hz, H-3' and 5'), 7.71 (2H, d, J = 8.5 
Hz, H-2' and 6'); 13C NMR (125 MHz, CD3OD): δ 191.5 (s, C-
1), 163.3 (s, C-4'), 132.7 (d, C-2' and 6'), 128.0 (s, C-1'), 114.9 
(d, C-3' and 5'), 52.9 (q, C-7'), 36.5 (d, C-2), 27.8 (t, C-3), 17.4 
(q, C-5), 11.0 (q, C-4). ESIMS (positive) m/z 193 [M + H]+; 
HRESIMS m/z 193.1234 (calcd for C12H17O2, 193.1223). 
 
Alternariol (2): white solid; UV (MeOH) λmax (log ε) 255, 
297, 335 nm; 1H NMR (DMSO-d6, 500 MHz): δ 2.68 (3H, s, 
H-7'), 6.34 (1H, d, J = 1.7 Hz, H-4), 6.61 (1H, d, J = 2.3 Hz, 
H-3'), 6.69 (1H, d, J = 2.3 Hz, H-5'), 7.21 (1H, d, J = 1.7 Hz, 
H-6); 13C NMR (125 MHz, DMSO-d6): δ 166.3 (s, C-5), 165.2 
(s, C-7), 164.6 (s, C-3), 159.0 (s, C-4'), 153.2 (s, C-2'), 138.8  
(s, C-6'), 138.1 (s, C-1), 118.1 (d, C-5'), 109.5 (s, C-1'), 105.0 
(d, C-6), 102.1 (d, C-3'), 101.5 (d, C-4), 97.8 (s, C-2), 25.8 (q, 
C-7'). ESIMS (positive) m/z 259 [M + H]+. HRESIMS m/z 
259.0612 (calcd for C14H11O5, 259.0601). 
 
(–)-(3R)-Mellein methyl ether (3): white solid; [α] 24D   – 
324.0 (c 0.52, MeOH); UV (MeOH) λmax 243, 306 nm; 1H 
NMR (DMSO-d6, 500 MHz): δ 1.31 (3H, d, J = 7.0 Hz, H-9), 
2.87 (2H, m, H-4), 3.77 (3H, s, H-10), 4.45 (1H, m, H-3), 6.85 
(1H, d, J = 7.5 Hz, H-5), 7.00 (1H, d, J = 8.5 Hz, H-7), 7.47 
(1H, dd, J = 8.5, 7.5 Hz, H-6); 13C NMR (125 MHz, CD3OD): δ 166.4 (s, C-1), 163.5 (s, C-8), 144.8 (s, C-4a), 137.3 (d, C-6), 
121.6  (d, C-5), 115.1 (s, C-8a), 113.2 (d, C-7), 77.1 (d, C-3), 
57.4 (q, C-10), 37.6 (t, C-4), 21.8 (q, C-9); ESIMS (positive) 
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